Overview

Fulvestrant 500mg in Patients With Advanced Breast Cancer

Status:
Unknown status
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
Fulvestrant 500mg in Patients With Advanced Breast Cancer
Details
Lead Sponsor:
Fudan University
Treatments:
Estradiol
Fulvestrant